Silk Road Medical Inc (SILK) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket
 


Silk Road Medical Inc   (NASDAQ: SILK)


Silk Road Medical Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Silk Road Medical Inc's ROI in the second quarter of 2024?
Silk Road Medical Inc recorded a cumulative net loss of $-57 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -24.03%.

Within the Healthcare sector 346 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 1716 to 3344.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM 9.2 % 23.31 % 48.7 % 83.16 % 62.56 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 238 231 235 237 239
Return On Investment (TTM) -24.03 % -22.68 % -23.47 % -23.06 % -24.54 %
SILK's Overall Ranking # 3344 # 1716 # 1811 # 2124 # 2650
Seq. Investment Change TTM -0.11 % -0.81 % -1.06 % 11.4 % 12.8 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -57 -53 -56 -55 -53




Return On Investment SILK's Ranking
Within: No.
Industry # 107
Sector # 347
Overall # 3344

Return On Investment Statistics
High Average Low
-22.68 %
-47.98 %
-346.65 %
(Mar 31 2024)   (Mar 31 2019)



  News about Silk Road Medical Inc Return on Investment ROI

Silk Road Medical Celebrates 100,000 Transcarotid Artery Revascularization (TCAR) Procedures, Reinforcing Leadership in Minimally Invasive Vascular Interventions

July 30, 2024

Silk Road Medical: Revolutionizing Transcarotid Artery Revascularization with Groundbreaking Milestone of 100,000 Procedures
Study-backed and supported by extensive clinical publications, Silk Road Medical Inc has once again proven its expertise in delivering positive outcomes through its innovative Transcarotid Artery Revascularization (TCAR) procedures. This milestone achievement of surpassing 100,000 successful TCAR procedures reinforces Silk Road Medical s position as a leader in the field of minimally invasive vascular interventions.
TCAR, pioneered by Silk Road Medical, is a cutting-edge technique that combines the benefits of carotid endarterectomy (CEA) and carotid artery stenting (CAS). It addresses the risks associated with more traditional treatment methods while delivering improved patient outcomes. The procedure involves accessing the carotid arteries through a small incision just above the collarbone, significantly reducing the potential for stroke compared to other approaches.






Financial Statements
Silk Road Medical Inc's II. Quarter Investments $ 238 Millions SILK's Balance sheet
Silk Road Medical Inc's II. Quarter Income $ -17 Millions Quarterly SILK's Income Statement
SILK's Income by Division See SILK's Income by Division


SILK Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 235 245 131 157 120
Y / Y Investment Growth -4.15 % 87.83 % -16.83 % 30.29 % -
Net Income in Millions -56 -55 -50 -47 -52
Y / Y Net Income Growth - - - - -
Annual Return On Investment -23.72 % -22.44 % -38.16 % -30.18 % -43.51 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SILK's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SILK's Competitors
Subscribers only: Roi for Silk Road Medical Inc's Suppliers
Subscribers only: Return On Investment for SILK's Customers

Other Ratios
SILK's Roa SILK's Inventory Turnover Ratio SILK's Growth Rates SILK's Dividend Statistics
SILK's Profitability Ratios SILK's Asset Turnover Ratio SILK's Dividend Growth
SILK's Roe SILK's Valuation Ratios SILK's Financial Strength Ratios SILK's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI


Date modified: 2026-09-26T07:36:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.